Italy to require tax labels on e-cigarette liquids from November

Nov.01.2024

Italy requires tax labels on e-cigarette liquids starting November 1; online nicotine sales face bans and licensing risks starting January 2025.

All e-cigarette liquids sold in authorized Italian stores will have to carry a tax label from November 1, according to an October 31 report by Sigmagazine, which aims to tighten regulation of e-liquids.

This rule also applies to e-commerce sites with tax warehouses, but a separate regulation will ban these sites from selling nicotine products from January 1, 2025.

Retailers without a license to sell tobacco products, inhalable vapor products, or other taxable items may sell remaining stock to the public until April 30, 2025, provided they can prove the products were purchased before April 30, 2024. Another key date is December 31, 2025, by which any remaining stock that meets tax label requirements but lacks new label features (e.g., safety warnings, addiction helpline numbers) must be disposed of.

Retailers who continue selling unlabeled e-cigarette liquids risk license suspension and, in severe cases, license revocation and criminal charges for smuggling violations.

References:

[1] Fine tempo massimo per sigarette elettroniche e aromi senza contrassegno

Also Read:

[1] Italian Finance Minister: E-cigarette License Extended to 4 Years, New Online Sales Regulations Coming

[2] Italy Bans 876 Websites for Illegal E-Liquid Sales, Imposes Strict Ad Rule

[3] Italian Authorities Seize 50 Millions Illegal Tobacco Products Online

[4] Italian Parliament to Investigate Tobacco Taxation and Regulation Policies

[5] Rome City Council to Ban E-Cigarette Sales in District

[6] Italy Cracks Down on Illegal Online Tobacco and Vape Sales

[7] Bolzano City Council Passes Full Smoking Ban at Lido

[8] Italian Authorities Crack Down on Tobacco and E-cigarette Websites

#Europe #E-liquids #Italy #Regulation

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA Rolls Out Online PMTA Platform, a Move That 2Firsts Analysts Say Could Pull Grey-Market Products Toward Formal Compliance

FDA’s launch of a web-based PMTA system signals faster reviews and, 2Firsts experts say, a possible inflection point for the U.S. e-cigarette market’s shift out of the grey zone.

Dec.04

Vape Company Takes FDA to Court for Stalling Premarket Decision for Half a Decade

California-based vape manufacturer Schwartz E-Liquid (USA Vape Lab) has sued the U.S. Food and Drug Administration (FDA) in federal court, alleging the agency unlawfully failed to issue a decision on its premarket application for flavored e-cigarette products for more than five years. The company is seeking a court order compelling the FDA to act within 90 days.

Nov.26 by 2FIRSTS.ai

IMiracle Announces 2025 R&D Progress with Over 2,200 Patent Applications Worldwide

IMiracle announces significant R&D progress in 2025, with over 2,200 patent applications globally and 900 authorized patents.

Dec.18 by 2FIRSTS.ai

U.S. Court Rules Zyn Marketing Dispute Can Proceed, Rejects Philip Morris International’s Bid to Dismiss

A U.S. federal court in Florida denied Philip Morris International and its subsidiaries’ motion to dismiss, allowing consumers to proceed with claims under the Florida Deceptive and Unfair Trade Practices Act alleging that Zyn nicotine pouches’ “tobacco-free” marketing is misleading. The court held that the allegations do not amount to a fraud claim and may move forward to the merits stage.